Logos Global Management LP

SEC CIK: 0001792126
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Logos Global Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overview All 13F holders of CRVS Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2025

Holdings of CRVS by Logos Global Management LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−450,000−100.0%	Sold out	Holders
Q1 2026	450,000	$6.58M	0.3%	−50,000−10.0%	Reduced	Holders
Q4 2025	500,000	$3.85M	0.3%	+500,000	New	Holders